Evonik Industries AG (EVK):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Evonik Industries AG (EVK) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9819
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Evonik Industries AG (Evonik), a subsidiary of RAG-Stiftung, is a specialty chemicals company. Its product portfolio includes surfactants, polymers, resins, additives and others. The company’s products find application in various markets, including adhesives and sealants, automotive, agriculture, coatings, composites, construction, design, electronics and telecommunications, environment and utilities, food, feed, plastics, pharmaceuticals and others. Evonik also offers process technology, technical, logistics and engineering services. It operates major production, facilities in Germany, Belgium, the US China, Singapore and other countries. The company has operational presence in North America, Asia, Africa, South America, Europe and other countries. Evonik is headquartered in Essen, Nordrhein-Westfalen, Germany.

Evonik Industries AG (EVK) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Evonik Industries AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Evonik Industries AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Evonik Industries AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Evonik Industries AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Evonik Industries AG, Medical Devices Deals, 2012 to YTD 2018 9
Evonik Industries AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Evonik Industries AG, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Evonik Industries to Acquire Technology Package from METabolic Explorer 11
Venture Financing 12
Numaferm Raises Additional Funds through Seed Financing 12
JeNaCell Raises Funds in Series A Financing 13
Partnerships 14
BioDelivery Sciences Enters into Co-Development Agreement with Evonik 14
Colorcon Enters Into Co-Marketing Agreement With Evonik Industries For Acryl-EZE 15
DiFusion Technologies Enters Into Co-Development Agreement With Evonik Degussa For CleanFUZE 16
Losan Pharma Enters into Agreement with Evonik Industries 17
Evonik Industries Enters Into Co-Development Agreement With Brain 18
Debt Offering 19
Evonik Industries Raises USD559.3 Million in Private Placement of 0.75% Bonds Due 2028 19
Evonik Industries Raises USD727 Million in Private Placement of Bonds Due 2021 20
Evonik Industries Raises USD839 Million in Private Placement of 0.375% Bonds Due 2024 21
Asset Transactions 22
Deb Group Acquires Stoko Professional Skin Care Business From Evonik 22
Acquisition 23
Evonik Industries Acquires Transferra Nanosciences 23
Evonik Industries AG – Key Competitors 24
Evonik Industries AG – Key Employees 25
Evonik Industries AG – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Joint Venture 28
Recent Developments 29
Strategy And Business Planning 29
Jun 27, 2017: Evonik Expands North American Contract Development and Manufacturing Capabilities for Advanced Injectables 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Evonik Industries AG, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Evonik Industries AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Evonik Industries AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Evonik Industries AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Evonik Industries AG, Deals By Therapy Area, 2012 to YTD 2018 8
Evonik Industries AG, Medical Devices Deals, 2012 to YTD 2018 9
Evonik Industries AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Evonik Industries to Acquire Technology Package from METabolic Explorer 11
Numaferm Raises Additional Funds through Seed Financing 12
JeNaCell Raises Funds in Series A Financing 13
BioDelivery Sciences Enters into Co-Development Agreement with Evonik 14
Colorcon Enters Into Co-Marketing Agreement With Evonik Industries For Acryl-EZE 15
DiFusion Technologies Enters Into Co-Development Agreement With Evonik Degussa For CleanFUZE 16
Losan Pharma Enters into Agreement with Evonik Industries 17
Evonik Industries Enters Into Co-Development Agreement With Brain 18
Evonik Industries Raises USD559.3 Million in Private Placement of 0.75% Bonds Due 2028 19
Evonik Industries Raises USD727 Million in Private Placement of Bonds Due 2021 20
Evonik Industries Raises USD839 Million in Private Placement of 0.375% Bonds Due 2024 21
Deb Group Acquires Stoko Professional Skin Care Business From Evonik 22
Evonik Industries Acquires Transferra Nanosciences 23
Evonik Industries AG, Key Competitors 24
Evonik Industries AG, Key Employees 25
Evonik Industries AG, Subsidiaries 26
Evonik Industries AG, Joint Venture 28

List of Figures
Evonik Industries AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Evonik Industries AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Evonik Industries AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Evonik Industries AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Evonik Industries AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Evonik Industries AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Evonik Industries AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Evonik Industries AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Evonik Industries AG, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Evonik Industries AG (EVK):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CorEnergy Infrastructure Trust Inc (CORR):石油・ガス:M&Aディール及び事業提携情報
    Summary CorEnergy Infrastructure Trust Inc (CorEnergy) is an energy infrastructure real estate investment trust. The company owns assets in the midstream and downstream US energy sectors that perform functions, such as pipelines, storage terminals, and transmission and distribution assets. Its portf …
  • Pacira Pharmaceuticals Inc (PCRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Pacira Pharmaceuticals Inc (Pacira) discovers, develops, manufactures and commercializes drugs based on its proprietary DepoFoam drug delivery technology. Its lead product candidate, Exparel (bupivacaine liposome injectable suspension) is an amide-type local anesthetic indicated for infiltra …
  • Rheinmetall AG:企業の戦略・SWOT・財務情報
    Rheinmetall AG - Strategy, SWOT and Corporate Finance Report Summary Rheinmetall AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Sunrise Coal LLC:企業の戦略・SWOT・財務分析
    Sunrise Coal LLC - Strategy, SWOT and Corporate Finance Report Summary Sunrise Coal LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Wolverine Power Supply Cooperative Inc:企業の戦略的SWOT分析
    Wolverine Power Supply Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Klepierre SA:企業のM&A・事業提携・投資動向
    Klepierre SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Klepierre SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • ams AG (AMS):企業の財務・戦略的SWOT分析
    Summary ams AG (ams), formerly austriamicrosystems AG is a technology company that manufactures and markets semiconductor products. The company's products comprise audio systems, environmental sensors, light sensors, smart light management, spectral sensing, CMOS imaging sensors, medical imaging and …
  • Black Box Corp:企業の戦略的SWOT分析
    Black Box Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Enea SA (ENA):企業の財務・戦略的SWOT分析
    Enea SA (ENA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Colgate-Palmolive (India) Ltd:企業の戦略・SWOT・財務情報
    Colgate-Palmolive (India) Ltd - Strategy, SWOT and Corporate Finance Report Summary Colgate-Palmolive (India) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Sprott Resource Holdings Inc. (SRHI):企業の財務・戦略的SWOT分析
    Sprott Resource Holdings Inc. (SRHI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Cobalt International Energy, Inc. (CIE)-石油・ガス分野:企業M&A・提携分析
    Summary Cobalt International Energy, Inc. (Cobalt) is an independent upstream oil and gas company. The company explores for, develops and produces oil and gas from its assets. It has assets in deepwater US Gulf of Mexico and offshore Angola and Gabon in West Africa. The company’s Gulf of Mexico asse …
  • Sentara Healthcare Inc:企業の戦略的SWOT分析
    Sentara Healthcare Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Sri Ayudhya Capital Public Company Limited:企業の戦略・SWOT・財務分析
    Sri Ayudhya Capital Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Sri Ayudhya Capital Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • LRAD Corporation:企業の戦略・SWOT・財務情報
    LRAD Corporation - Strategy, SWOT and Corporate Finance Report Summary LRAD Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Chemo Espana SA-製薬・医療分野:企業M&A・提携分析
    Summary Chemo Espana SA (Chemo Group) is a pharmaceutical company, which conducts research, development, manufacture, sales and marketing of active pharmaceutical ingredients (APIs), finished dosage forms and branded pharmaceuticals. Its product portfolio includes steroids, hormones and antibiotics …
  • Oncternal Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Oncternal Therapeutics Inc (Oncternal) is a clinical-stage oncology company that develops therapies for rare and common cancers. The company’s pipeline compounds include cirmtuzumab and TK216. Its compounds are primarily focused on exciting targets which are uniquely expressed within cancer …
  • The Netherlands Cancer Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary The Netherlands Cancer Institute (NCI) is a research institute that offers cancer research and treatment services. The institute conducts research in the areas of cell biology, diagnostic oncology, medical oncology, molecular carcinogenesis, biochemistry, biological stress response, gene reg …
  • CONSOL Energy Inc.:企業のM&A・事業提携・投資動向
    CONSOL Energy Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CONSOL Energy Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • The Walsh Group:企業の戦略・SWOT・財務分析
    The Walsh Group - Strategy, SWOT and Corporate Finance Report Summary The Walsh Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆